Home / Auditor changes / ANI PHARMACEUTICALS INC

3/5ANI PHARMACEUTICALS INC (ANIP): Auditor change

Filed 2026-04-07 路 Form 8-K 路 Accession 0001023024-26-000034 small

Market data

Price before filing: $77.2 (2026-04-06 close, split/dividend-adjusted)
Market cap at flag: $1.66B (2026-04-07) 路 Latest: $1.53B (2026-10-16)

What happened next

WindowANIPSPYvs SPY
30 days+8.7%+11.0%-2.3%2026-05-07
90 days+10.2%+14.3%-4.1%2026-07-06
180 days-6.0%+18.2%-24.2%2026-10-05

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: 7 insiders sold $4.0M (18 sales)
30 days after: 1 insider sold $39K (1 sale)

DateInsiderTypeSharesPriceValue10b5-1 planSource
2026-01-13Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sale500$84.33$42KyesForm 4
2026-02-12Mutz Christopher
HEAD OF RARE DISEASE
Sale7,032$76.55$538KyesForm 4
2026-02-13Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sale500$76.80$38KyesForm 4
2026-02-19Davis Krista
SVP, CHIEF HR OFFICER
Sale2,084$77.53$162KyesForm 4
2026-02-20Davis Krista
SVP, CHIEF HR OFFICER
Sale1,730$77.99$135KyesForm 4
2026-02-20Mutz Christopher
HEAD OF RARE DISEASE
Sale5,323$78.02$415KyesForm 4
2026-03-02Mutz Christopher
HEAD OF RARE DISEASE
Sale417$74.00$31KyesForm 4
2026-03-03Gutwerg Ori
SVP, GENERICS
Sale2,060$76.50$158KnoForm 4
2026-03-03Walsh Patrick D
Director
Sale6,000$74.23$445KnoForm 4
2026-03-05CAREY STEPHEN P.
SVP & CFO
Sale3,312$75.42$250KnoForm 4
2026-03-05CAREY STEPHEN P.
SVP & CFO
Sale4,000$75.56$302KnoForm 4
2026-03-06Davis Krista
SVP, CHIEF HR OFFICER
Sale1,485$75.00$111KyesForm 4
2026-03-06Mutz Christopher
HEAD OF RARE DISEASE
Sale2,121$74.22$157KyesForm 4
2026-03-09Davis Krista
SVP, CHIEF HR OFFICER
Sale5,087$74.13$377KyesForm 4
2026-03-09Mutz Christopher
HEAD OF RARE DISEASE
Sale3,602$74.18$267KyesForm 4
2026-03-11Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Sale4,772$74.91$357KnoForm 4
2026-03-13Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sale500$72.62$36KyesForm 4
2026-03-13Mutz Christopher
HEAD OF RARE DISEASE
Sale3,162$71.64$227KyesForm 4
2026-04-07: red flag filed
2026-04-13Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sale500$77.95$39KyesForm 4

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-01-07 to 2026-05-07. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"(the "Company") notified EisnerAmper LLP ("EisnerAmper") that EisnerAmper would be dismissed as the Company's independent registered public accounting firm."

Quoted from the filing. Source

What this means

The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.

Type: dismissed
Disagreements reported: no
Former auditor: EisnerAmper LLP · New auditor: Ernst & Young LLP

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.